How much is the Cancer Biological Therapy Market worth?

Global market size is worth USD 225 Billion by 2032.

What was the value of the Cancer Biological Therapy Market in 2023?

In 2023, the market value stood at USD 110 Billion.

What is the CAGR of Cancer Biological Therapy Market?

The global Cancer Biological Therapy Market is growing at a CAGR of 7.6% during the forecast period 2022 to 2033.

Who are the major players operating in the Cancer Biological Therapy Market?

Merck & Co., Inc., F. Hoffmann-La Roche Ltd, Novartis AG, Amgen Inc., Bristol-Myers Squibb Company, Celgene, Eli Lilly and Company (US), EnGeneIC, Pfizer, Intas Pharmaceuticals Ltd., Astellas, Otsuka, Teva Pharmaceutical Industries Ltd., Bayer AG, GlaxoSmithKline PLC, AbbVie Inc., Astellas Pharma Inc., Seattle Genetics, Takeda Pharmaceuticals, Spectrum Pharmaceuticals, Bausch Health Companies Inc., Johnson & Johnson Services, Inc., AstraZeneca PLC, and Other Key Players.

Which region will lead the Cancer Biological Therapy Market?

North America is estimated to be the fastest-growing region during the forthcoming years.

Global Cancer Biological Therapy Market By Product Type (Vaccines, Monoclonal Antibodies, and Cancer Growth Blockers), By Route of Administration (Oral and Injectable), By End-User (Hospitals & Clinics, Cancer Research Centres, and Laboratories), By Distribution Channel (Specialized Cancer Treatment Centers, Hospital Pharmacies, and Retail Pharmacies), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032

Published date: Oct 2023
Report ID: 66398
Number of Pages: 346
Format:

- Merck & Co., Inc.
- Hoffmann-La Roche Ltd
- Novartis AG
- Amgen Inc.
- Bristol-Myers Squibb Company
- Celgene
- Eli Lilly and Company (US)
- EnGeneIC
- Pfizer
- Intas Pharmaceuticals Ltd.
- Astellas
- Otsuka
- Teva Pharmaceutical Industries Ltd.
- Bayer AG
- GlaxoSmithKline PLC
- AbbVie Inc.
- Astellas Pharma Inc.
- Seattle Genetics
- Takeda Pharmaceuticals
- Spectrum Pharmaceuticals
- Bausch Health Companies Inc.
- Johnson & Johnson Services, Inc.
- AstraZeneca PLC
- Other Key Players